CLINICAL_TRIALS
trial_result
· 2020-04-06
Clinical Trial Update: HD17 for Intermediate Stage Hodgkin Lymphoma [Phase 3]
Summary
A Phase 3 clinical trial update for HD17 in intermediate stage Hodgkin lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Cologne | Conditions: Hodgkin Lymphoma | Phase 3 | Status: COMPLETED